Coronavirus Disease 2019 (COVID-19)
FDA is working with U.S. government partners, including CDC, and international partners to address the pandemic.
Topic Paragraphs
Featured Topics
Recalls, Market Withdrawals, & Safety Alerts
The FDA provides information gathered from press releases and other public notices about certain recalls of FDA-regulated products. Not all recalls have press releases or are posted on this website
Dec 16
Manzanola Feeds is Recalling Certain Lots of Top of the Rockies Alfalfa Cubes due to Possible Clostridium botulinum Health Risk
Animal & Veterinary
Dec 16
TFP Nutrition Initiated Voluntary Recall of 16 lb. Bags of HEB TEXAS PETS Indoor Complete Dry Cat Food Because of Possible Salmonella Health Risk
Animal & Veterinary, Food & Beverages
Dec 15
Something South African LLC Recalls the Peppercorn Collection Gift Set Because of Possible Health Risk
Food & Beverages
Paragraph Header
FDA VOICES: PERSPECTIVES FROM FDA EXPERTS
FDA’s Cybersecurity Modernization Action Plan
CMAP will leverage Artificial Intelligence and Machine Learning technologies to enhance cyber detection and response capabilities.
Focusing on Prevention to Safeguard Infant Formula
FDA is working with infant formula manufacturers to maximize production and taking steps to assure the public that infant formula is and will remain safe.
FDA Continues to Advance Medicines for Children
Increasing the availability of safe and effective medicines for children is a key priority for the U.S. Food and Drug Administration.
Recently Published Guidances
Dec 19
CVM GFI #152 Evaluating the Safety of Antimicrobial New Animal Drugs with Regard to Their Microbiological Effects on Bacteria of Human Health Concern
Animal & Veterinary
Dec 15
Hypertension Indication: Drug Labeling for Cardiovascular Outcome Claims
Drugs
Dec 15
Circumstances that Constitute Delaying, Denying, Limiting, or Refusing a Drug or Device Inspection (December 2022)
Drugs, Medical Devices